An in silico molecular strategy to uncover medication against SARS CoV-2 from coastal grass Spinifex littoreus (Burm f.) Merr.
DOI:
https://doi.org/10.14719/pst.5315Keywords:
3CL protease, drug-likeness, molecular docking, spike glycoprotein, Spinifex littoreusAbstract
The coronavirus (COVID-19) caused a global public health disaster and every outbreak is believed to have a natural cure. Hence, this investigation aims to identify a suitable target to inhibit viral multiplication using Spinifex littoreus and to control the binding of human ACE2 receptors with the viral protein through molecular docking. This investigation aids in finding a SARS-CoV-2 antagonist in the coastal grass S. littoreus. Through GC-MS analysis, 22 different phytochemical compounds were screened from the methanolic and chloroform extracts of S. littoreus. Using Swiss ADME software, the drug-likeness properties of the screened compounds were examined. Of the 22 screened compounds, only seven adhere to Lipinski's rule of five. The compound 1-methylene-2b-hydroxymethyl-3,3-dimethyl-4b -(3-methylbut-2-enyl)-cyclohexane was docked against 3CLPRO and the spike (S) glycoprotein of SARS-CoV-2. The free binding energies of the target proteins are -6.12 kcal/mol and -6.0 kcal/mol, respectively. A stronger ligand -protein interaction results in lower binding energy. These findings could contribute to the development of a new medication for the treatment of SARS-CoV-2.
Downloads
References
Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141-54. https://doi.org/10.1038/s41579-020-00459-7
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The protein data bank. Nucleic Acids Res. 2000;28(1):235-42. https://doi.org/10.1093/nar/28.1.235
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet. 2020;395(10224):565-74. https://doi.org/10.1038/s41579-020-00459-7
Brian DA, Baric RS. Coronavirus genome structure and replication. Curr Top Microbiol Immunol. 2005;287:1-30. https://doi.org/10.1007/3-540-26765-4_1
Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, et.al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450-54. https://www.nature.com/articles/nature02145
Krichel B, Falke S, Hilgenfeld R, Redecke L, Uetrecht C. Processing of the SARS-CoV pp1a/ab nsp7–10 region. Biochem J. 2020;477(5):1009-19. https://doi.org/10.1042/BCJ20200029
Phillipson JD. Phytochemistry and medicinal plants. Phytochem. 2001;56(3):237-43. https://doi.org/10.1016/S0031-9422(00)00456-8
Larcher W. Physiological plant ecology: Ecophysiology and stress physiology of functional groups. (4th Ed), Springer: New York; 2003. https://dx.doi.org/10.1007/978-3-662-05214-3
Sen UK, Bhakat RK. Ethnobotanical study on sand-dune based medicinal plants and traditional therapies in coastal Purba Medinipur district, West Bengal, India. European J Med Plants. 2018;26(2):1-9. http://dx.doi.org/10.9734/EJMP/2018/46231
Neamsuvan O, Singdam P, Yingcharoen K, Sengnon N. A survey of medicinal plants in mangrove and beach forests from sating Phra Peninsula, Songkhla Province, Thailand. J Med Plants Res. 2012;6(12):2421-37. http://www.academicjournals.org/JMPR
Thirunavukkarasu P, Ramanathan T, Ramkumar L, Balasubramanian T. Antimicrobial effect of a coastal sand dune plant of Spinifex littoreus (Burm. f.) Merr. Curr Res J Biol. 2010;2(4):283-85. https://www.researchgate.net/publication/45266735
Shakila K. Bioactive flavonoids of Spinifex littoreus (Burm. f.) Merr- Investigation by ELISA method. J Stress Physiol Biochem. 2020;16(4):107-12.
Yogamoorthi A, Priya ES. Anti-inflammatory and analgesic property of methanolic extract of Spinifex littoreus (Burm. f.) Merr. J Environ Biol. 2006;27(2):271.
Idroes GM, Tallei TE, Idroes R, Riza M. The study of Calotropis gigantea leaf metabolites from Ie Brouk geothermal area Lamteuba-Aceh Besar using molecular docking. In: IOP Conf Series: Earth Environ Sci; 2021. 667(1):012072. https://doi.org/10.1088/1755-1315/667/1/012072
Shanmathi C, Ponmurugan P, Karthik N, Anita M, Ezhilarasu A, Rohini A. In silico analysis of various antiviral compounds against spike protein of COVID-19 using docking methods. Int J Engin Res Technol. 2020;9(11):55-60. https://www.researchgate.net/publication/352977008
Saki J, Shadnoush F, Arjmand R, Rahim F. In-silico identification of the best compound against Leishmania infantum: High throughput screening of all FDA approved drugs. Turkiye Parazitol Derg. 2019;43:158-64. http://doi.org/10.4274/tpd.galenos.2019.6290
Surti M, Patel M, Adnan M, Moin A, Ashraf SA, Siddiqui AJ, et. al. Ilimaquinone (marine sponge metabolite) as a novel inhibitor of SARS-CoV-2 key target proteins in comparison with suggested COVID-19 drugs: Designing, docking and molecular dynamics simulation study. RSC Adv. 2020;10(62):37707-20. https://doi.org/10.1039/D0RA06379G
Daina A, Zoete V. A boiled-egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem. 2016;11(11):1117-21. https://doi.org/10.1002/cmdc.201600182
Tice CM. Selecting the right compounds for screening: Does Lipinski's rule of 5 for pharmaceuticals apply to agrochemicals? Pest Manag Sci. 2001;57(1):3-16. https://doi.org/10.1002/1526-4998(200101)57:1%3C3::AID-PS269%3E3.0.CO;2-6
Mandlik V, Bejugam PR, Singh S. Application of artificial neural networks in modern drug discovery. In: Artificial neural network for drug design, delivery and disposition. Academic Press. 2016; p.123-39. https://doi.org/10.1016/B978-0-12-801559-9.00006-5
Brüssow H. The novel coronavirus–a snapshot of current knowledge. Microb Biotechnol. 2020;13(3):607-12. https://doi.org/10.1111/1751-7915.13557
Prajapati S, Sharma M, Kumar A, Gupta P, GV NK. An update on novel COVID-19 pandemic: A battle between humans and virus. Eur Rev Med Pharmacol Sci. 2020;24(10):5819-29. https://doi.org/10.26355/eurrev_202005_21377
Bailey D, Brown D. High-throughput chemistry and structure-based design: Survival of the smartest. Drug Discov Today. 2001;6(2):57-59. https://doi.org/10.1016/s1359-6446(00)01596-8
Moitessier N, Englebienne P, Lee D, Lawandi J, Corbeil AC. Towards the development of universal, fast and highly accurate docking/scoring methods: A long way to go. Br J Pharmacol. 2008;153(S1):7-26. https://doi.org/10.1038/sj.bjp.0707515
Chandran M, Vivek P, Kesavan D. Phytochemical screening and anti-bacterial studies in salt marsh plant extracts (Spinifex littoreus (Burm. f) Merr. and Heliotropium curassavicum L.). Int J Chemtech Res. 2014;6(9):4307-11. https://www.researchgate.net/publication/301655727
El Fadili M, Er-Rajy M, Kara M, Assouguem A, Belhassan A, Alotaibi A, et al. QSAR, ADMET In silico pharmacokinetics, molecular docking and molecular dynamics studies of novel bicyclo (aryl methyl) benzamides as potent GlyT1 inhibitors for the treatment of schizophrenia. Pharmaceuticals. 2022;15(6):670. https://doi.org/10.3390/ph15060670
Reyaz S, Tasneem A, Rai GP, Bairagya HR. Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study. J Mol Graph Model. 2021;109:108021. https://doi.org/10.1016/j.jmgm.2021.108021
Thurakkal L, Singh S, Roy R, Kar P, Sadhukhan S, Porel M. An in-silico study on selected organosulfur compounds as potential drugs for SARS-CoV-2 infection via binding multiple drug targets. Chem Phys Lett. 2021;763:138193. https://doi.org/10.1016/j.cplett.2020.138193
Lobo-Galo N, Terrazas-López M, Martinez-Martinez A, Diaz-Sanchez AG. FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication. J Biomol Struct Dyn. 2021;39(9):3419-27. https://doi.org/10.1080/07391102.2020.1764393
Tran QH, Nguyen QT, Tran TT, Tran TD, Le MT, Trinh DT, et. al. Identification of small molecules as potential inhibitors of interleukin 6: A multi-computational investigation. Mol Diversity. 2023;27(5):2315-30. https://doi.org/10.1007/s11030-022-10558-7
Downloads
Published
Versions
- 07-03-2025 (2)
- 28-02-2025 (1)
How to Cite
Issue
Section
License
Copyright (c) 2025 J Vedhamani, I P Ajithkumar
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright and Licence details of published articles
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Open Access Policy
Plant Science Today is an open access journal. There is no registration required to read any article. All published articles are distributed under the terms of the Creative Commons Attribution License (CC Attribution 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited (https://creativecommons.org/licenses/by/4.0/). Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
